The bone morphogenetic proteins (BMPs). Their role in renal fibrosis and renal function

Journal of Nephrology

Volumn 16, Issue 2, 2003, Pages 179-185

  Klahr, Saulo ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

Diabetic nephropathy; Renal fibrosis; Ureteral obstruction

Indexed keywords

BONE MORPHOGENETIC PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GELATINASE A; OSTEOGENIC PROTEIN 1; STREPTOZOCIN; BIOLOGICAL MARKER; TRANSFORMING GROWTH FACTOR BETA;

ANALYTICAL PARAMETERS; CLINICAL PROTOCOL; DIABETIC NEPHROPATHY; DRUG EFFICACY; DRUG MECHANISM; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HOMEOSTASIS; INTERSTITIAL FLUID; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TUBULE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; URETER OBSTRUCTION; ACUTE KIDNEY FAILURE; ANIMAL; CHRONIC KIDNEY FAILURE; DISEASE MODEL; FIBROSIS; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION TEST; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; RAT; RISK ASSESSMENT;

ANIMALS; BIOLOGICAL MARKERS; BONE MORPHOGENETIC PROTEINS; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; FIBROSIS; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; PROGNOSIS; RATS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA;

EID: 0042521151     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Ducy P, Karsenty G. The family of bone morphogenetic proteins. Kidney Int 2000; 57: 2207-14.
2. Harland RM. The transforming growth factor beta family and induction of the vertebrate mesoderm: Bone morphogenetic proteins are vertical inducers. Proc Natl Acad Sci 1994; 71: 10243-46.
3. Hogan BL. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes Dev 1996; 10: 1580-94.
4. Wolfman NM, Hattesley G, Cox K. Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5,6 and 7 numbers of the TGF-beta gene family. J Clin Invest 1997; 100: 321-30.
5. Constam DB, Roberston EJ. Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. J Cell Biol 1999; 144: 139-49.
6. Schulunegger MP, Gruter MG. An unusual feature revealed by the crystal structure at 2.2: A resolution of human transforming growth factor-beta 2. Nature 1992; 358: 430-34.
7. Daopin S, Piez KA, Ogawa Y, Davies OR. Crystal structure of transforming growth factor-beta 2. An unusual fold for the super family. Science 1992; 257: 369-73.
8. McPherron AC, Lee SJ. GDF-3 and GDF-9. Two new numbers of the transforming growth factor-beta super family containing a novel pattern of cysteins. J Biol Chem 1993; 268: 3444-49.
9. Massague J, Weis-Garcia F. Serine/threonine kinase receptors: Mediators of transforming growth factor beta family signals. Cancer Surv 1996; 27: 41-64.
10. Massague J. TGF beta transduction. Annu Rev Biochem 1998; 67: 753-91.
11. Lyons KM, Hogan BL, Robertson EJ. Colocalization of BMP 7 and BMP 2 RNAs suggests that these factors cooperatively mediate tissue interactions during murine development. Mech Dev 1995; 50: 71-83.
12. Schultheiss TM, Burch JB, Lassar AB. A role for bone morphogenetic proteins in the induction of cardiac myogenesis. Genes Dev 1997; 15: 451-62.
13. Dudley AT, Lyons KM, Robertson EJ. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 1995; 9: 2795-807.
14. Luo G, Hofmann C, Bronckers AL, Sohocki M, Bradley A, Karsenty G. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 1995; 9: 2808-820.
15. Hruska KA, Guo G, Wozniak M, Martin D, Miller S, Liapis H, Loveday K, Klahr S, Sampath TK, Morrissey J. Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol (Renal Physiol) 2000; 280: F130-3.
16. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992; 20: 1-17.
17. Eddy AA. Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 1994; 5: 1273-87.
18. Ishidoya S, Morrissey JJ, McCracken R, Klahr S. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int 1996; 49: 1110-19.
19. Morrissey JJ, Klahr S: Transcription factor NF-B. Regulation of renal fibrosis during ureteral obstruction. Semin Nephrol 1998; 18: 603-11.
20. Truong LD, Sheikh-Hamad D, Chakraborty S, Suki WN. Cell apoptosis and proliferation in obstructive uropathy. Semin Nephrol 1998; 18: 641-51.
21. Savill J. Apoptosis and the kidney (Editorial). J Am Soc Nephrol 1994; 5: 12-21.
22. Morrissey J, Hruska K, Guo G, Wang S, Chen Q, Klahr S. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 2002; (suppl 1): S14-21.
23. Wang S, Chen Q, Eisenbeis P, Strebeck F, Liapis H, Idleburg C, Morrissey JJ, Klahr S, Hruska KA. Bone Morphogenic Protein-7 (BMP-7), an effective therapy for chronic kidney disease (CKD). (Abstract) J Am Soc Nephrol 2002; 13: 45A.